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Abstract
Accurate prediction of disease trajectories is critical for early identification and
timely treatment of patients at risk. Conventional methods in survival analysis
are often constrained by strong parametric assumptions and limited in their abil-
ity to learn from high-dimensional data, while existing neural network models
are not readily-adapted to the longitudinal setting. This paper develops a novel
convolutional approach that addresses these drawbacks. We present MATCH-Net:
a Missingness-Aware Temporal Convolutional Hitting-time Network, designed
to capture temporal dependencies and heterogeneous interactions in covariate
trajectories and patterns of missingness. To the best of our knowledge, this is
the first investigation of temporal convolutions in the context of dynamic predic-
tion for personalized risk prognosis. Using real-world data from the Alzheimer’s
Disease Neuroimaging Initiative, we demonstrate state-of-the-art performance with-
out making any assumptions regarding underlying longitudinal or time-to-event
processes—attesting to the model’s potential utility in clinical decision support.
1 Introduction
In Alzheimer’s disease—the annual cost of which exceeds $800 billion globally [1]—the effectiveness
of therapeutic treatments is often limited by the challenge of identifying patients at early enough
stages of progression for treatments to be of use. As a result, accurate and personalized prognosis in
earlier stages of cognitive decline is critical for effective intervention and subject selection in clinical
trials. Conventional statistical methods in survival analysis often begin by choosing explicit functions
to model the underlying stochastic process [2–7]. However, the constraints—such as linearity and
proportionality [8, 9] in the popular Cox model—may not be valid or verifiable in practice.
In spite of active research, a conclusive understanding of Alzheimer’s disease progression remains
elusive, owing to heterogeneous biological pathways [10, 11], complex temporal patterns [12, 13],
and diverse interactions [14, 15]. Hence Alzheimer’s data is a prime venue for leveraging the potential
advantages of deep learning models for survival. Neural networks offer versatile alternatives by
virtue of their capacity as general-purpose function approximators, able to learn—without restrictive
assumptions—the latent structure between an individual’s prognostic factors and odds of survival.
Contributions. Our goal is to establish a novel convolutional model for survival prediction, using
Alzheimer’s disease as a case study for experimental validation. Primary contributions are threefold:
First, we formulate a generalized framework for longitudinal survival prediction, laying the foundation
for effective cross-model comparison. Second, our proposal is uniquely designed to capitalize on
longitudinal data to issue dynamically updated survival predictions, accommodating potentially
informative patterns of data missingness, and combining human input with model predictions. Third,
we propose methods for deriving clinically meaningful insight into the model’s inference process.
Finally, we demonstrate state-of-the-art results in comparison with comprehensive benchmarks.
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2 Problem formulation
Let there be N patients in a study, indexed i ∈ {1, ..., N}. Time is treated as a discrete dimension of
fixed resolution δ > 0. Each longitudinal datum consists of the tuple (t,xi,t, si,t), where xi,t is the
vector of covariates recorded at time t, and si,t is the binary survival indicator. Let random variable
Ti,surv denote the time-to-event, Ti,cens the time of right-censoring, and Ti = min{Ti,surv, Ti,cens}. Per
convention, we assume that censoring is not correlated with the eventual outcome [16–18]. Let the
complete longitudinal dataset be given by X = {〈(t,xi,t, si,t)〉tit=0}Ni=1. Then we can define
Xi,t,w = 〈(t′,xi,t′ , si,t′)〉t′∈T where T = {t′ : t− w ≤ t′ ≤ t} (1)
to be the set of observations for patient i extending from time t into a width-w window of the past,
where parameter w depends on the model under consideration. Given longitudinal measurements
in Xi,t,w, our goal is to issue risk predictions corresponding to length-τ horizons into the future.
Formally, given a backward-looking historical window (t − w, t], we are interested in the failure
function for forward-looking prediction intervals (t, t+ τ ]; that is, we want to estimate the probability
Fi(t+ τ |t, w) = P(Ti,surv ≤ t+ τ |Ti,surv > t,Xi,t,w) (2)
of event occurrence within each prediction interval. Observe that parameterizing the width of the
historical window results in a generalized framework—for instance, a Cox model only utilizes the
most recent measurement; that is, w = 1. At the other extreme, recurrent models may consume the
entire history; that is, w = t. As we shall see, the best performance is in fact obtained via a flexible
intermediate approach—that is, by learning the optimal width of a sliding window of history.
3 MATCH-Net
Figure 1: (a) The MATCH-Net architecture, with τmax = 5δ. (b) Illustration of temporal convolutions
acting over feature channels. (c) The longitudinal context within which MATCH-Net operates, as well
as the network’s prediction targets in association with the sliding window input mechanism.
We propose MATCH-Net: a Missingness-Aware Temporal Convolutional Hitting-time Network, inno-
vating on current approaches in three respects. Dynamic prediction: Existing deep learning models
issue prognoses on the basis of information from a single time point [19–29], potentially discarding
valuable information in the presence of longitudinal data. We investigate temporal convolutions
in capturing heterogeneous representations of temporal dependencies among observed covariates,
enabling truly dynamic predictions on the basis of historical information. Informative missingness:
Current survival methods rely on the common assumption that the timing and frequency of covariate
measurements is uninformative [18, 30]. By contrast, our model is missingness-aware—that is, we
explicitly account for informative missingness by learning correlations between patterns of missing-
ness and disease progression. Human input: Instead of issuing predictions solely on the basis of
quantitative clinical measurements, we optionally incorporate clinicians’ most recent diagnoses of
patient state into model estimates to examine the incremental informativeness of subjective input.
Each innovation is a source of gain in performance (see Section 4; further details in the appendix).
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MATCH-Net accepts as input a sliding-window of observed covariates Xi,t,w, as well as a parallel
binary mask of missing-value indicators Zi,t,w taking on values of one to denote missing covariate
measurements. In addition, the network optionally accepts a one-hot vector ri,t describing the most
recent clinician diagnosis of Alzheimer’s disease progression. Starting from the base of the network,
the convolutional block first learns representations of longitudinal covariate trajectories by extracting
local features from temporal patterns. After each layer, filter activations from the auxiliary branch are
concatenated with those in the main branch. Then, the fully-connected block captures more global
relationships by combining local information. Finally, the output layers produce failure estimates
yˆi,t = [Fˆi(t+ δ|t, w), ..., Fˆi(t+ τmax|t, w)] (3)
for pre-specified prediction intervals, where τmax is the maximal horizon desired. This convolutional
dual-stream architecture explicitly captures representations of temporal dependencies within each
stream, as well as between covariate trajectories and missingness patterns in association with disease
progression. This accounts for the potential informativeness of both irregular sampling (i.e. intervals
between consecutive clinical visits may vary) and asynchronous sampling (i.e. not all features are
measured at the same time) [31, 32]. This also encourages the network to distinguish between actual
measurements and imputed values, reducing sensitivity to specific imputation methods chosen. The
final architecture uses convolutions of length l = 5δ, with more filters per layer in the main branch.
Loss function. With the preceding notation, the negative log-likelihood of a single empirical result
si,t+τ and model estimate Fˆi(t+ τ |t, w) in relation to some input window Xi,t,w is given by
li,t,τ (θ) = −[si,t+τ log Fˆi(t+ τ |t, w) + (1− si,t+τ ) log(1− Fˆi(t+ τ |t, w))] (4)
where θ denotes the parameters of the network. The total loss function is then computed to simulta-
neously take into account the quality of predictions for all prediction horizons τ , all times t available
along each patient’s longitudinal trajectory, and all patients i ∈ {1, ..., N} in the survival dataset:
l(θ) =
δ2∑N
i=1
∑ti
j=1 τi
N∑
i=1
ti/δ∑
j=1
τi/δ∑
k=1
α(i, (j − 1)δ, kδ) · li,(j−1)δ,kδ (5)
where τi = min{ti − t, τmax} accounts for failure or right-censoring. This is a natural generalization
of the log-likelihood in [24] to accommodate longitudinal survival. Weight function α(i, t, τ) allows
trading off the relative importance of different patients, time steps, and prediction horizons. First,
this allows standardizing patient contributions with α(i, t, τ) ∝ 1/ti, thereby counteracting the bias
against patients with shorter survival durations. Second, in the context of heavily imbalanced classes,
this allows up-weighting positive instances—that is, input windows that correspond to actual failure.
4 Experiments
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) study data is a longitudinal survival dataset
of per-visit measurements for 1,737 patients [1]. The data tracks disease progression through clinical
measurements at 1/2-year intervals, including quantitative biomarkers, cognitive tests, demographics,
and risk factors. Our objective is to predict the first stable occurrence of Alzheimer’s disease for each
patient. Further information on the dataset, preparation, and training can be found in the appendix.
Benchmarks. We evaluate MATCH-Net against both traditional longitudinal methods in survival
analysis and recent deep learning approaches; the former includes Cox landmarking and joint
modeling methods, and the latter includes static and dynamic multilayer perceptrons and recurrent
neural network models. Performance is evaluated on the basis of the area under the receiver operating
characteristic curve (AUROC) and the area under the precision-recall curve (AUPRC), both computed
with respect to prediction horizons τ . Five-fold cross validation metrics are reported in Table 1.
Performance. MATCH-Net produces state-of-the-art results, consistently outperforming both con-
ventional statistical and neural network benchmarks. Gains are especially apparent in AUPRC
scores—improving on the MLP by an average of 15% and on joint models by 16% across all horizons,
and by 27% and 26% for one-step-ahead predictions. To understand the sources of improvement, we
observe a 4% gain in AUPRC from introducing the sliding window mechanism (MLP to S-MLP), a
9% gain from incorporating temporal convolutions (S-MLP to S-TCN), and a further 2% gain from
accommodating informative missingness (S-TCN to MATCH-Net). In addition, including the most
recent clinician diagnosis results in a further 17% gain (further details located in the appendix).
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Table 1: Cross validation performance for τmax = 5δ and δ = 1/2 years: MATCH-Net without clinician
input, sliding-window temporal convolutional networks (S-TCN) and multilayer perceptrons (S-MLP).
Benchmarks include fully-convolutional networks (FCN) [33] adapted for sequence-based survival
prediction, Disease Atlas (D-Atlas) [34], baseline recurrent neural networks (RNN) including GRUs
and LSTMs, static multilayer perceptrons (MLP), as well as conventional statistical methods for
survival analysis—including joint modeling (JM) and Cox landmarking (LM). Bold values indicate
best performance, and asterisks next to benchmark results indicate statistically significant difference
(p-value < 0.05) from MATCH-Net result. More detailed breakdown of gains are found the appendix.
τ MATCH-Net S-TCN S-MLP FCN D-Atlas RNN MLP JM LM
AUROC 0.5 0.962 0.961 0.959 0.954 0.959 0.949* 0.948* 0.913* 0.909*
1.0 0.942 0.941 0.932 0.930 0.929 0.930 0.930 0.917* 0.914*
1.5 0.902 0.902 0.897 0.895 0.892 0.891 0.890 0.881 0.878
2.0 0.909 0.908 0.904 0.903 0.896 0.901 0.895 0.894 0.890
2.5 0.886 0.884 0.881 0.883 0.884 0.883 0.874 0.883 0.878
AUPRC 0.5 0.594 0.580 0.500 0.536 0.517 0.464* 0.469* 0.473* 0.469*
1.0 0.513 0.505 0.447 0.453 0.423 0.410* 0.435 0.415* 0.412*
1.5 0.373 0.367 0.354 0.357 0.364 0.340 0.340 0.319 0.325
2.0 0.390 0.380 0.364 0.375 0.352 0.355 0.359 0.362 0.367
2.5 0.384 0.381 0.371 0.365 0.360 0.365 0.356 0.366 0.363
Figure 2: Average saliency map indicating feature and temporal influence, computed using slopes of
partial dependence on sample of numerical features across sliding window (w = 5δ; δ = 1/2 years).
Visualization. From the preceding, we observe the largest gains by introducing convolutions. While
this is consistent with our motivating hypothesis that convolutions are better able to capture temporal
patterns, clinicians often desire a degree of transparency into the prediction process [35, 36]. We
adopt the partial dependence approach in [37] to understand the input-output relationship, as well as
examining the utility of convolutions. For each observed covariate d, we want to approximate how
the estimated failure function varies based on the value of xdt,w. We define the dependence
E
X
(−d)
t,w
[Fˆ (t+ τ |Xt,w)] ≈ δ∑N
i=1 ti
N∑
i=1
ti/δ∑
j=1
Fˆ ((j − 1)δ + τ |xd(j−1)δ,w,X(−d)(j−1)δ,w) (6)
where xdt,w ∪X(−d)t,w = Xt,w. By evaluating Equation 6 on the values xdt,w present in the data, the
influence of each covariate can be measured by estimating its slope. For a global picture of what
impact each feature and time step has on the model’s predictions, we compute the influence for all
features to produce an average saliency map [38, 39] highlighting the effect of convolutional layers.
All else equal, absent convolutions we see that having worse covariate values any time step almost
invariably has an upward impact on risk (i.e. negative impact on survival). On the other hand, with
temporal convolutions we see that having worse covariate values at earlier time steps may result in a
downward impact on risk (i.e. positive impact on survival), suggesting that convolutions may better
facilitate modeling relative movements (e.g. sudden declines) than simply paying attention to levels.
Further visualizations for added perspective on input-output relationships are found in the appendix.
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APPENDIX
Example use
While various settings may benefit from MATCH-Net as a matter of clinical decision support, we
illustrate one possible application within the context of personalized screening. Figure 3 shows the
historical risk trajectory and forward risk estimates for a randomly selected ADNI patient. During the
first seven years of bi-annual visits, the patient exhibits cognitively normal behavior, and the MATCH-
Net risk estimates—computed via measured biomarkers and neuropsychological tests—reflect this
steady clinical state (see historical trajectory in blue). In fact, as of precisely seven years of follow-up,
the predicted 30-month forward risk remains less than 10% (see predicted trajectory in orange).
Figure 3: Example application of MATCH-Net for personalized risk scoring.
However, two clinical visits later, when the patient returns for regular checkup and clinical measure-
ments, the projected 30-month forward risk jumps to over 50% (see predicted trajectory in red). In
this situation, the clinician is immediately alerted to the sudden increase in risk of dementia, and
may decide to advise more frequent checkups, or to administer a wider range of tests and biomarker
measurements in the immediate term to better assess the overall risk in light of the recent downturn.
In fact, as it turns out in this case, the patient is indeed diagnosed with Alzheimer’s disease at t = 10
years, shedding light on MATCH-Net’s potential as an early warning and subject selection system.
Related work
Table 2: Summary of primary improvements by related work
Model Non-Linearity
Deep
Learning
Direct-to-
Probability
Time-
Variance
Dynamic
Prediction
Cox (1972) 7 N/A N/A 7 7
Faraggi & Simon (1995) 3 7 7 7 7
Katzman et al. (2016) 3 3 7 7 7
Luck et al. (2017) 3 3 3 7 7
Lee et al. (2018) 3 3 3 3 7
(This study) (2018) 3 3 3 3 3
The first study to investigate neural networks formally in the context of time-to-event analysis was
done by [19]. By swapping out the linear functional in the Cox model for the topology of a hidden
layer, their nonlinear proportional hazards approach was extended to other models for censored data,
such as [4] and [20]. In 2016, [21] were the first to apply modern techniques in deep learning to
survival, in particular without prior feature selection or domain expertise. While previous studies
following [19]’s model generally produced mixed results [22, 23], [21] demonstrated comparable or
superior performance of multilayer perceptrons in relation to conventional statistical methods.
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Instead of predicting the hazard function as an intermediate objective, [24] first proposed—and [25]
further developed—an alternative approach to predict survival directly for grouped time intervals. In
2017, [27] combined the use of the Cox partial likelihood with the goal of predicting probabilities for
pre-specified time intervals. Inspired by the work of [26] on multi-task logistic regression models for
survival, they generalized the idea to deep learning via multi-task multilayer perceptrons.
Recently, [29] and [28] in 2018 proposed learning the distribution of survival times directly, making
no assumptions regarding the underlying stochastic processes—in particular with respect to the
time-invariance of hazards. By being process-agnostic, [29] demonstrated significant improvements
over existing statistical, machine learning, and neural network survival models on multiple real and
synthetic datasets. In the context of Alzheimer’s disease, [40] studied the use of medical image
sequences for classifying patient progression. More pertinently, [34] used recurrent networks to
forecast disease trajectories with ADNI data, but relied on the explicit assumption of exponential
distributions. Finally, building on these developments, one of the main contributions of this study is
the use of temporal convolutions for dynamic survival prediction—while making no assumptions,
and allowing the associations between covariates and risks to evolve over time (see Table 2).
Details on dataset
We are primarily interested in the clinical status for each patient at any given time. An official
diagnosis is recorded at each patient’s visit, and consists of two attributes. First, each diagnosis may
be either stable or transitive. The former consists of stable diagnoses of normal brain functioning
(“NL”), mild cognitive impairment (“MCI”), or Alzheimer’s disease (“AD”), and the latter consists
of preliminary diagnoses indicating transitions between these categories, which may take the form of
either conversions or reversions. Conversions indicate a forward progression in the disease trajectory,
and reversions indicate a regression back towards an earlier stage of the disease.
Figure 4: State space of clinical diagnoses.
Patients may remain in stable or transition diagnosis states for any duration at a time. The average
patient who receives a transition diagnosis is observed to persist in that state for one year, while some
patients do not exit this state until almost 5 years have elapsed. Patients who receive a transition
diagnosis may not actually be confirmed with a subsequent stable diagnosis; in fact, less than half of
the transition diagnoses for dementia were confirmed by a stable diagnosis at the next step, and almost
one quarter are never followed by a stable diagnosis at any point until right-censoring. In addition,
patients often actually undergo reversion transitions back towards earlier stages of the disease; in fact,
over 5% of the study population receive reversion diagnoses at some point in time.
Note on class imbalance. The per-patient failure rate is 14% (243 patients out of the total 1,737).
However, given the online nature of the sliding window mechanism in training and testing, the
effective fraction of observations with positive event labels for any prediction horizon is around 2%.
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Table 3: Summary and description of variables used in ADNI dataset.
Type Min Max Mean S.D. Missing
Event (AD) Categorical - - - - 30.1%
Static
Age Numeric 5.4E+01 9.1E+01 7.4E+01 7.2E+00 0.0%
APOE4 (Risk) Numeric 0.0E+00 2.0E+00 5.4E-01 6.6E-01 0.1%
Education Level Numeric 4.0E+00 2.0E+01 1.6E+01 2.9E+00 0.0%
Ethnicity Categorical - - - - 0.0%
Gender Categorical - - - - 0.0%
Marital Status Categorical - - - - 0.0%
Race Categorical - - - - 0.0%
Biomarker
Entorhinal Numeric 1.0E+03 6.7E+03 3.4E+03 8.1E+02 49.2%
Fusiform Numeric 7.7E+03 3.0E+04 1.7E+04 2.8E+03 49.2%
Hippocampus Numeric 2.2E+03 1.1E+04 6.7E+03 1.2E+03 46.6%
Intracranial Numeric 2.9E+02 2.1E+06 1.5E+06 1.7E+05 37.6%
Mid Temp Numeric 8.0E+03 3.2E+04 1.9E+04 3.1E+03 49.2%
Ventricles Numeric 5.7E+03 1.6E+05 4.2E+04 2.3E+04 41.6%
Whole Brain Numeric 6.5E+05 1.5E+06 1.0E+06 1.1E+05 39.7%
Cognitive
ADAS (11-item) Numeric 0.0E+00 7.0E+01 1.1E+01 8.6E+00 30.1%
ADAS (13-item) Numeric 0.0E+00 8.5E+01 1.8E+01 1.2E+01 30.7%
CRD Sum of Boxes Numeric 0.0E+00 1.8E+01 2.2E+00 2.8E+00 29.7%
Mini Mental State Numeric 0.0E+00 3.0E+01 2.7E+01 4.0E+00 29.9%
RAVLT Forgetting Numeric -1.2E+01 1.5E+01 4.2E+00 2.5E+00 30.9%
RAVLT Immediate Numeric 0.0E+00 7.5E+01 3.5E+01 1.4E+01 30.7%
RAVLT Learning Numeric -5.0E+00 1.4E+01 4.0E+00 2.8E+00 30.7%
RAVLT Percent Numeric -5.0E+02 1.0E+02 6.0E+01 3.8E+01 31.4%
Data preparation
Since the ADNI dataset is an amalgamation from multiple related studies, most features are sparsely
populated. Features with less than half of the entries missing are retained, leaving 18 numeric and
4 categorical features (see Table 3); the latter are represented by one-hot encoding, resulting in
16 binary features. Consistent with existing Alzheimer’s studies, patients are aligned according to
time elapsed since baseline measurements [41–43]. Timestamps are mapped onto a discrete axis
with a fixed resolution of δ = 1/2-year intervals; where multiple measurements qualify for the same
destination, the most recent measurement per feature takes precedence. Original measurements were
made at roughly 1/2-year intervals, so we observe that the average absolute deviation between original
values and final timestamps amounts to an insignificant 4 days (i.e. less than 2% of each interval).
Where measurements are missing, values are reconstructed using zero-order hold interpolation. In
addition, due to the fixed-width nature of the sliding window, the input tensor Xi,t,w for initial
prediction times t < w − δ correspond to left-truncated information t− w + δ < 0; feature values
are therefore extrapolated backwards for all intervals of the form [−w + δ,−δ]. Note that regardless
of the imputation mechanism, information on original patterns of missingness—due to truncation,
irregular sampling, and asynchronous sampling alike [31, 32]—is preserved in the missing-value
mask Zi,t,w provided in parallel to the network. Finally, to improve numerical conditioning, all
features are normalized with empirical means and standard deviations from the training set data.
Training procedure
Training begins with input tuple (X,Z,R), where X = {〈Xi,t,w〉tit=0}Ni=1, Z = {〈Zi,t,w〉tit=0}Ni=1,
and R = {〈ri,t〉tit=0}Ni=1, and terminates with a set of calibrated network weights θ. The network
is trained until convergence, up to a maximum of 50 epochs. Training loss is only computed for
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event labels corresponding to actual recorded clinical visits (i.e. timestamps with recorded covariate
values); neither imputed nor forward-filled labels are included. Analogous to our total loss function
definition, the convergence metric is the sum of performance scores across all prediction tasks,
C =
τmax/δ∑
k=1
β(kδ) · AUROCkδ + γ(kδ) · AUPRCkδ (7)
where β(τ), γ(τ) optionally allow trading off the relative importance between the two measures and
different horizons. In this study we simply use the unweighted sum, although any convex combination
would be valid. Empirically, results are not meaningfully improved by favoring one metric over the
other. Elastic net regularization is used, and validation performance is computed every 10 iterations.
For early stopping, validation scores serve as proxies for generalization error. Positive instances are
oversampled to counteract class imbalance. To augment training data, artificial labels for dummy
events of the form τ = 0 are generated, and positive labels are filled forward for all horizons τ > τ0
where τ0 corresponds to the first failure for that example. Patients diagnosed with Alzheimer’s at
baseline (20%) are excluded from testing and validation, since survival is undefined in those cases.
Table 4: Hyperparameter selection ranges for random search.
Hyperparameter Selection Range
Connected Layers 1, 2, 3, 4, 5
Convolutional Layers 1, 2, 3, 4, 5
Dropout Rate 0.1, 0.2, 0.3, 0.4, 0.5
Epochs for Convergence 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Learning Rate 1e-4, 3e-4, 1e-3, 3e-3, 1e-2, 3e-2
L1-Regularlisation None, 1e-4, 3e-4, 1e-3, 3e-3, 1e-2, 3e-2, 1e-1
L2-Regularization None, 1e-4, 3e-4, 1e-3, 3e-3, 1e-2, 3e-2, 1e-1
Minibatch Size 32, 64, 128, 256, 512
Number of Filters (Covariates) 32, 64, 128, 256, 512
Number of Filters (Masks) 8, 16, 32, 64, 128
Oversample Ratio None, 1, 2, 3, 5, 10
Recurrent Unit State Size 1×, 2×, 3×, 4×, 5×
Width of Connected Layers 32, 64, 128, 256, 512
Width of Convolutional Filters 3, 4, 5, 6, 7, 8, 9, 10
Width of Sliding Window 3, 4, 5, 6, 7, 8, 9, 10
For Cox landmarking, we use the implementation in [44] for interval-censored data, fitting a sequence
of proportional hazards regression models for observation groups. Optimal groupings are determined
by exhaustive search in 1/2-year increments. Preliminary feature-selection is performed by stepwise
regression for the best candidate model, using the implementation of [45]. For joint modeling,
we adopt the common two-stage method in [46], first fitting linear mixed effects sub-models for
significant variables, then fitting landmarking models based on mean estimates from the sub-models.
In both cases, consistent with literature, time is defined as years since initial follow-up [41–43].
For all neural network models, hyperparameter optimization is carried out via 100 iterations of
random search(see Table 4). In addition, activation functions are also searched over for gating units
in recurrent network cells. Model selection is performed on the basis of final composite scores—as in
Equation 7—for each candidate. We use 5-fold cross validation to evaluate performance, stratified at
the patient level—that is, patients are randomly selected into datasets for training (60%), validation
(20%), and testing (20%), with the ratio of positive patients (i.e. those for which at least one sliding
window contains at least one outcome of failure) to negative patients is kept uniform across folds.
Further analysis
In addition, we utilize output scatters to aid our understanding of the input-output relationship. We
use MC dropout to generate average responses by explicitly varying one input feature at a time [47]
in equation 6. This is done by either (1) varying only the final value of the measurement within the
sliding window, or by (2) varying all values of the measurement the same time. While the latter gives
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insight into how the response changes with respect to a difference in levels, the former sheds light
on how the response is affected by a sudden change instead. Interestingly in the case of temporal
convolutions, for multiple features (Figure 5 shows the MMSE and CDRSB features as examples)
the response is actually stronger to final value changes. This effect is not present in any feature
for multilayer perceptrons. In light of the performance of convolutional models, this is consistent
with our hypothesis that they appear able to learn more complex temporal patterns than multilayer
perceptrons; in this case, these results suggest that a patient who experiences a sudden decline in
certain features is expected to fare worse than one who has always scored just as poorly all along.
Figure 5: Comparison of output scatters for changes in all values within sliding window (red) versus
changes in the final value only (blue). Convolutional models show stronger responses in the latter.
Sources of gain
While the advantage of using multilayer perceptrons over traditional statistical survival models has
been studied (see [29] for example), here we account for the additional sources of gain from our design
choices. Table 5 (a) shows the initial benefit from incorporating longitudinal histories of covariate
measurements. Recurrent networks are used as a reasonable starting point; improvements—where
positive—are marginal at best. (b) However, experiments on differenced data—capturing relative
movements without absolute levels—indicate substantial informativeness (see df -RNN trained on
differences vs. joint models trained on levels). (c) Utilizing limited sliding windows instead of
recurrent cells shows promising improvements, boosting average AUPRC by 4% over both RNN
and MLP models. (d) The addition of temporal convolutions produces incremental AUPRC gains
of 9%. (e) Accommodating informative missingness by introducing the dual-stream architecture
results in further incremental AUPRC gains of 2%. Compared with the joint modeling baseline,
MATCH-Net achieves average AUPRC improvements of 15% and one-step-ahead improvements
of 26%. (f) Furthermore, incorporating the most recent clinician input (MATCH-Net+) improves
AUPRC by an additional 17%. While the distribution of gains skews near-term with our default
choices of α, β, and γ (i.e. unweighted by τ ), alternate distributions may be obtained via appropriate
weight functions depending on deployment context. (g) Finally, using MATCH-Net as an example, we
observe individual and cumulative benefits due to miscellaneous design choices applied to all models.
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Table 5: Source-of-gain accounting. Bold values indicate best performance. Note that AUROC is
much less sensitive than AUPRC in the context of highly imbalanced classes like the ADNI data [48].
(a) Gain from Covariate History
τ RNN MLP
AUROC 0.5 0.949 ±0.009 0.948 ±0.010
1.0 0.930 ±0.012 0.930 ±0.011
1.5 0.891 ±0.026 0.890 ±0.027
2.0 0.901 ±0.025 0.895 ±0.029
2.5 0.883 ±0.031 0.874 ±0.039
AUPRC 0.5 0.464 ±0.079 0.469 ±0.064
1.0 0.410 ±0.060 0.435 ±0.056
1.5 0.340 ±0.067 0.340 ±0.067
2.0 0.355 ±0.068 0.359 ±0.065
2.5 0.365 ±0.087 0.356 ±0.085
(b) Informativeness of Differences
df -RNN JM
0.913 ±0.026 0.913 ±0.036
0.830 ±0.020 0.917 ±0.016
0.700 ±0.057 0.881 ±0.029
0.712 ±0.059 0.894 ±0.034
0.708 ±0.083 0.883 ±0.036
0.494 ±0.057 0.473 ±0.072
0.386 ±0.036 0.415 ±0.042
0.213 ±0.058 0.319 ±0.044
0.241 ±0.078 0.362 ±0.050
0.217 ±0.096 0.366 ±0.064
(c) Gain from Limited Window
τ S-MLP RNN
AUROC 0.5 0.950 ±0.009 0.949 ±0.009
1.0 0.932 ±0.012 0.930 ±0.012
1.5 0.897 ±0.025 0.891 ±0.026
2.0 0.904 ±0.026 0.901 ±0.025
2.5 0.881 ±0.035 0.883 ±0.031
AUPRC 0.5 0.500 ±0.066 0.464 ±0.079
1.0 0.447 ±0.056 0.410 ±0.060
1.5 0.354 ±0.061 0.340 ±0.067
2.0 0.364 ±0.054 0.355 ±0.068
2.5 0.371 ±0.084 0.365 ±0.087
(d) Gain from Temporal Convolutions
S-TCN S-MLP
0.961 ±0.005 0.950 ±0.009
0.941 ±0.007 0.932 ±0.012
0.902 ±0.025 0.897 ±0.025
0.908 ±0.026 0.904 ±0.026
0.884 ±0.032 0.881 ±0.035
0.580 ±0.066 0.500 ±0.066
0.505 ±0.065 0.447 ±0.056
0.367 ±0.063 0.354 ±0.061
0.380 ±0.052 0.364 ±0.054
0.381 ±0.085 0.371 ±0.084
(e) Gain from Missingness-Awareness
τ MATCH-Net S-TCN
AUROC 0.5 0.962 ±0.004 0.961 ±0.005
1.0 0.942 ±0.007 0.941 ±0.007
1.5 0.902 ±0.024 0.902 ±0.025
2.0 0.909 ±0.027 0.908 ±0.026
2.5 0.886 ±0.033 0.884 ±0.032
AUPRC 0.5 0.594 ±0.058 0.580 ±0.066
1.0 0.513 ±0.059 0.505 ±0.065
1.5 0.373 ±0.065 0.367 ±0.063
2.0 0.390 ±0.059 0.380 ±0.052
2.5 0.384 ±0.081 0.381 ±0.085
(f) Gain from Most Recent Diagnosis
MATCH-Net+ MATCH-Net
0.989 ±0.003 0.962 ±0.004
0.951 ±0.008 0.942 ±0.007
0.897 ±0.026 0.902 ±0.024
0.901 ±0.024 0.909 ±0.027
0.885 ±0.024 0.886 ±0.033
0.862 ±0.037 0.594 ±0.058
0.636 ±0.043 0.513 ±0.059
0.393 ±0.082 0.373 ±0.065
0.380 ±0.051 0.390 ±0.059
0.375 ±0.066 0.384 ±0.081
(g) Gain from oversampling (O), label forwarding (L), and elastic net (E) for MATCH-Net
AUROC AUPRC
O L E 0.5 1.0 1.5 2.0 2.5 0.5 1.0 1.5 2.0 2.5
7 7 7 0.946 0.923 0.895 0.902 0.888 0.493 0.418 0.348 0.351 0.355
7 7 3 0.956 0.938 0.901 0.906 0.886 0.534 0.477 0.368 0.381 0.384
7 3 7 0.944 0.920 0.888 0.896 0.886 0.435 0.413 0.334 0.351 0.357
7 3 3 0.961 0.941 0.902 0.908 0.887 0.575 0.502 0.370 0.384 0.377
3 7 7 0.946 0.923 0.894 0.902 0.887 0.499 0.425 0.352 0.365 0.365
3 7 3 0.956 0.938 0.901 0.907 0.887 0.533 0.473 0.362 0.379 0.385
3 3 7 0.942 0.918 0.885 0.894 0.881 0.448 0.404 0.332 0.348 0.361
3 3 3 0.962 0.942 0.902 0.909 0.886 0.594 0.513 0.373 0.390 0.384
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